This Article is From May 06, 2013

Glenmark profit may miss estimates: StarMine

Glenmark Pharmaceuticals Ltd could miss January-March earnings consensus forecast, according to Thomson Reuters StarMine data.

StarMine's SmartEstimates, which places greater emphasis on forecasts by top-rated analysts, shows Glenmark could report a net profit of Rs 156 crore for the quarter, compared with a mean consensus estimate of Rs 168 crore.

Shares in Glenmark were up 1.9 per cent at 12:24 a.m. The company will announce its earnings on Tuesday.

Copyright: Thomson Reuters 2013